|1|Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). (24346130)
Wong J.S.... Harris J.R.
|2|Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. (24291376)
van Steenbergen L.N.... van de Poll-Franse L.V.
|3|The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ. (23851504)
Ory V.... Riegel A.T.
|4|Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node. (23089490)
Fitzpatrick-Swallow V.L.... Pinder S.E.
|5|FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast. (23712790)
Lal A.... Hwang E.S.
|6|Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis. (23281914)
Osako T.... Akiyama F.
|7|Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up. (22932738)
SztrA^kay A.... Bamberg F.
|8|Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor. (23870857)
Kim J.Y.... Noh D.Y.
|9|Neuroendocrine ductal carcinoma in situ, comedo type, of the breast detected by screening mammography: a potentially pre-invasive counterpart of high grade neuroendocrine tumours. (22437750)
Kawasaki T.... Katoh R.
|10|Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature. (22606601)
Gunia S.R.... Mamounas E.P.
|11|The evaluation of the immunoexpression of Her2A^neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast. (23188444)
Fota G.L.... Ciurea R.N.
|12|Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. (22488610)
Partridge A.H.... Schnitt S.J.
|13|Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007. (22340960)
Puig-Vives M.... Marcos-Gragera R.
|14|Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast. (22804792)
Hollingsworth A.B.... Stough R.G.
|15|Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. (23083502)
Yoshida A.... Tsunoda H.
|16|Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer. (23216911)
Zhang W.... Zhang X.H.
|17|HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. (22361634)
Rakovitch E.... Paszat L.
|18|Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. (22392043)
Kuerer H.M.... Hunt K.K.
|19|Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy. (22445178)
Catteau X.... NoAl J.C.
|20|Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. (21885281)
Thill M.... Dittmer C.
|21|Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive inA situ ductal carcinoma (IDCA +A DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade. (20143189)
Papantoniou V.... Antsaklis A.
|22|Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients. (21108045)
Tunon-de-Lara C.... Avril A.
|23|Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ. (21741518)
Miyake T.... Noguchi S.
|24|Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. (21042943)
Yu K.D.... Shao Z.M.
|25|Use of preoperative MRI among older women with ductal carcinoma in situ and locally invasive breast cancer: Data Points # 13 (23115802)
Tuttle T.M.... Virnig B.A.
|26|Her-2 positive ductal carcinoma in situ is an independent predictor of tumor recurrence. (21805692)
Shand J.A.... Howe A.
|27|Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer: Data Points # 15 (23115801)
Jarosek S.... Virnig B.A.
|28|Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. (21079099)
Kurniawan E.D.... Mann G.B.
|29|Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. (20663721)
Muggerud A.A.... WAornberg F.
|30|Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis. (20848183)
Wang S.Y.... Kane R.
|31|Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. (20071685)
Virnig B.A.... Kane R.L.
|32|Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. (20427430)
Kerlikowske K.... Tlsty T.D.
|33|Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. (20469955)
Haque R.... Habel L.A.
|34|Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast. (19201736)
Lester T.... Tang P.
|35|Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. (19473551)
Qi L.... Berg A.V.
|36|Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ. (19675453)
Aulmann S.... Sinn H.P.
|37|Comparative evaluation of the erbB2 and hormone receptor status of neighboring invasive and in situ components of ductal carcinomas of the breast. (20108215)
Peres R.M.... Sarian L.O.
|38|High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision. (19691836)
Fadare O.... Ghofrani M.
|39|Aromatase expression in invasive and in situ ductal carcinoma present in the same breast]. (20191218)
Oliveira V.M.... Aoki T.
|40|P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma. (19190693)
Shamloula M.M.... Saied E.M.
|41|The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern. (17618822)
Altundag K.... Harputluoglu H.
|42|Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast. (17119686)
Menezes M.V.... Zeferino L.C.
|43|An in situ carcinoma of the pancreas forming 2 invasive ductal carcinomas. (16025010)
Sanada Y.... Nishimura R.
|44|p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2. (15318938)
Vestey S.B.... Winters Z.E.
|45|Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation. (15528970)
Thomassen M.... Gerdes A.M.
|46|Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast. (12461058)
Rice A.J.... Quinn C.M.
|47|Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. (11345835)
Leong A.S.... Suthipintawong C.
|48|Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in situ hybridization (FISH) analysis. (11114860)
Komoike Y.... Koyama H.
|49|Malignant myoepithelioma associated with in situ and invasive ductal carcinoma. Description of a case and review of the literature]. (9471611)
Scarpellini F.... Foschini M.P.
|50|High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. (8968105)
Man S.... Brook J.D.